Contact

Location: Neuroscience Discipline; Daniel Lodge, Ph.D. lab

Department

Pharmacology

Hannah Elam

Graduate Student

Personal Statement:

Hannah is a graduate student in the Neuroscience discipline of the Integrated Biomedical Sciences program. She currently works in the laboratory of Daniel Lodge, Ph.D., in the Department of Pharmacology, where the focus of her research is investigating orexin receptor antagonists as novel therapeutics for post-traumatic stress disorder and comorbid psychosis. Outside of the laboratory, she serves as the Secretary for the Graduate Student Association and the Historian for WISDOM (Women in Science: Development, Outreach, and Mentorship).

Hobbies:

Bike riding, baking, traveling

Education

BS, Psychology - The University of Texas at Austin
BS, Molecular Biology - Texas Lutheran University

Awards & Accomplishments

1st Place, Graduate Student Oral Paper Competition, 124th Annual Meeting of the Texas Academy of Science, Virtual Conference – 2021

Predoctoral fellow on the Institutional National Research Service Award,  T32 NS082145 (NINDS) funded by the NIH Jointly Sponsored NIH Predoctoral Training Program in the Neurosciences – 2019 – 2020

Publications

List of all publications: https://www.ncbi.nlm.nih.gov/myncbi/1dkLab9Qha5kgd/bibliography/public/

 

Lectures, Posters, Presentations

Elam, H.B. Perez, S.M., Donegan, J.J., Lodge, D.J. Orexin receptor antagonists reverse aberrant dopamine activity and related behaviors in a rodent model of stress-induced psychosis. Long School of Medicine Research Week, UT Health San Antonio, April 2021. (Poster)

Elam, H.B. Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis. Graduate Student Oral Competition, Texas Academy of Science 124th Annual Meeting, Virtual Conference. February 2021. (Presentation)

Elam, H.B., Perez, S.M., Donegan, J.J., Lodge, D.J. Orexin receptor antagonists reverse aberrant dopamine activity and related behaviors in a rodent model of stress-induced psychosis. Poster #4. 27th Annual Graduate Student Symposium of the Department of Pharmacology, UT Health San Antonio, October 2020. (Poster)

Perez, S.M., Elam, H.B., Lodge, D.J. Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in rodent models of psychosis. ACNP 59th Annual Meeting. Orlando, FL: American College of Neuropsychopharmacology, 2020. Online. (Poster)

Elam, H.B., Donegan, J.J., Perez, S.M., Lodge, D.J. Suvorexant reverses stress induced psychosis-like behavior in a rodent model of PTSD. Program No. 780.28. 2019 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience, 2019. Online. (Poster)

Elam, H.B., Donegan, J.J., Perez, S.M., Lodge, D.J. Suvorexant reverses stress induced psychosis-like behavior in a rodent model of PTSD. Poster #5. 26th Annual Graduate Student Symposium of the Department of Pharmacology, UT Health San Antonio, October 2019. (Poster)

Elam, H.B., Donegan, J.J., Boley, A.M., Lodge, D.J. Suvorexant reverses stress induced psychosis-like behavior in a rodent model of PTSD. Poster #3. Mikiten Graduate Research Symposium, UT Health San Antonio, May 2019. (Poster)

Elam, H.B., Donegan, J.J., Boley, A.M., Lodge, D.J. Suvorexant reverses stress induced psychosis-like behavior in a rodent model of PTSD. Poster #13. Center for Biomedical Neuroscience Annual Retreat, UT Health San Antonio, May 2019. (Poster)